Replies to post #320 on BioCurex, Inc.(fka BOCX)

[JAZZ ONE]

Bocxman, I've been following your posts on RG for some time and have been holding 50,000 plus shares for more then a year. Just wanted you to know that perhaps there are others like myself who understand the potential with BOCX and appreciate your insights and positive outlook.

Now that I have joined this board perhaps I can help as well.

Thanks

[Headache]

Bocxman, that's a very cogent summary of the situation. The only outstanding question is timing: i.e., when will we see this independent verification of Biocurex's performance numbers for RECAF? This has been a matter of some debate. My own view, which I've posted on RB, is that such verification is still a few years away. This is because they'll need to demonstrate that the test can detect cancer at a very early stage (before patients are otherwise symptomatic). Sufficient time would be needed to determine if asymptomatic RECAF-positive patients do develop cancer.

Others have objected to my argument, suggesting that the RECAF imaging technology could ostensibly be used to verify the existence and location of early cancers. I'm not sure about this. What would be needed would be independent verification of the existence of cancer, not another RECAF-based test. So again we'd have to wait for more traditional diagnostic measures to verify the accuracy of the RECAF tests.

It's true that I'm thinking of establishing RECAF's usefulness as a test for very early detection, and that establishing its usefulness as an adjunctive test might involve less time.

I'd be interested in what others have to say about the timing issue. When are we likely to see independent results from Abbott or elsewhere that could raise the stock price?